A Phase 1 Study of Navlimetostat Tablet Formulations

NCT07544628 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Navlimetostat

Sponsor

Bristol-Myers Squibb